Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 3 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases |
VEGFA 2件: VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 4 | Bladder cancer 💬 10 genes, 23 drugs (DrugBank) and 22 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 5 | Bladder cancer 💬 10 genes, 23 drugs (DrugBank) and 22 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 6 | Bladder cancer 💬 10 genes, 23 drugs (DrugBank) and 22 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 7 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 8 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 9 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
VEGFA 2件: VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 10 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 37 drugs (DrugBank) and 42 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 11 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 37 drugs (DrugBank) and 42 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 12 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 37 drugs (DrugBank) and 42 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 13 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 14 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 15 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 16 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 17 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 18 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 19 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 20 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 21 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 22 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 23 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 24 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 25 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 26 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 27 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 28 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 29 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 30 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 31 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 32 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 33 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 34 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 35 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 36 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 37 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 38 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 39 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 40 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 41 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 42 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 43 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 44 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 45 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 46 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 47 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 48 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 49 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 50 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 51 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 52 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 53 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 54 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 55 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 56 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 57 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 58 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
PGF 3件: PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 59 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 60 | Ras signaling pathway 💬 35 genes, 53 drugs (DrugBank) and 62 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 61 | Relaxin signaling pathway 💬 19 genes, 30 drugs (DrugBank) and 38 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 62 | Relaxin signaling pathway 💬 19 genes, 30 drugs (DrugBank) and 38 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 63 | Relaxin signaling pathway 💬 19 genes, 30 drugs (DrugBank) and 38 diseases |
VEGFA 2件: VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 64 | Renal cell carcinoma 💬 12 genes, 15 drugs (DrugBank) and 19 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 65 | Renal cell carcinoma 💬 12 genes, 15 drugs (DrugBank) and 19 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 66 | Renal cell carcinoma 💬 12 genes, 15 drugs (DrugBank) and 19 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 67 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 68 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 69 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|
| 70 | VEGF signaling pathway 💬 21 genes, 53 drugs (DrugBank) and 90 diseases |
VEGFA 1件: VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 2件: 90, 166 💬
|
| 71 | VEGF signaling pathway 💬 21 genes, 53 drugs (DrugBank) and 90 diseases |
VEGFA 1件: VEGFA 💬
|
Bevacizumab Bevacizumab 💬
| Bevacizumab | 013 6件: 13, 34, 85, 87, 227, 280 💬
|
| 72 | VEGF signaling pathway 💬 21 genes, 53 drugs (DrugBank) and 90 diseases |
VEGFA 1件: VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 4件: 34, 166, 227, 301 💬
|